Chronic migraine, defined as fifteen or more headache days per month, affects an estimated two percent of the global population, and a significant portion of those patients are inadequately treated by oral medications alone. The failure is not always a matter of the wrong drug; often it reflects a delivery and mechanism problem that oral pharmacology is structurally limited to address. At Scottsdale Ketamine Clinic, we offer IV ketamine infusion therapy for chronic migraine at our Scottsdale and Phoenix locations — and understanding why the infusion approach works where oral treatments fall short is worth explaining in detail.
The Delivery Problem With Oral Migraine Medications
When you take an oral medication, it travels through the gastrointestinal tract before entering the bloodstream, undergoes first-pass metabolism in the liver, and reaches peak blood concentration on a timeline measured in hours rather than minutes. For acute migraine treatment, this delay is clinically significant: by the time a triptan or an analgesic reaches therapeutic concentration, the neurological cascade driving the migraine may be well advanced and less pharmacologically interruptible.
The absorption problem is compounded by a feature of migraine itself. During a migraine attack, gastric motility — the normal movement of the digestive system — slows dramatically in many patients, a phenomenon called gastroparesis. This means oral medications are absorbed even more slowly and unpredictably during the exact window when fast action matters most. Intravenous administration bypasses the gastrointestinal tract entirely, delivering medication directly to the bloodstream at a controlled, consistent rate. Peak concentration is reached in minutes rather than hours, and the delivery is not subject to the absorption variability that makes oral migraine treatment unreliable in a meaningful subset of patients.
The Mechanism Problem: What Oral Treatments Miss
Delivery timing is only part of the picture. The more fundamental issue for chronic migraine patients is that most oral medications target one or two specific steps in the migraine cascade without addressing the underlying neural sensitization that makes migraines chronic in the first place.
Chronic migraine involves a process called central sensitization, in which the nervous system’s pain-processing network becomes persistently hypersensitized to stimuli (National Center for Biotechnology Information). This is not the same as having a single migraine. Central sensitization means the threshold for triggering a migraine is persistently lowered — the nervous system has reorganized itself around a pain-amplifying state that conventional medications manage episode by episode but do not reverse at the system level.
The glutamate neurotransmitter system is central to this sensitization process. Elevated glutamate activity and overactive NMDA receptors — the receptors responsible for amplifying pain signals — are consistent features of central sensitization in chronic migraine (National Center for Biotechnology Information). Triptans, CGRP inhibitors, and most preventive oral medications do not target the NMDA receptor. IV ketamine does. By blocking overactive NMDA receptors, ketamine interrupts the pain amplification cycle at a level that oral migraine medications were not designed to reach, and its neuroplastic effects — including the promotion of new neural connections — offer the possibility of recalibrating the sensitized state rather than simply dampening its output (National Center for Biotechnology Information).
What Happens at the Neural Level During an Infusion
The distinction between suppressing a migraine symptom and addressing the neural system sustaining migraines is more than semantic. When IV ketamine reaches the brain, its NMDA receptor blockade begins working within minutes on the overactive glutamate signaling that characterizes central sensitization. As the infusion proceeds, the hypersensitized pain-processing network is quieted — not by numbing sensation broadly, as an analgesic might, but by interrupting the specific excitatory mechanism driving abnormal pain amplification.
The neuroplastic effects of ketamine extend beyond the session itself. Repeated infusions promote BDNF synthesis and support the formation of new synaptic connections that can help normalize the sensitized neural architecture over time. For patients whose chronic migraines have persisted for years, this is not a rapid or guaranteed reversal — results vary by individual — but it represents a mechanism of action that addresses the system-level problem rather than applying a band-aid to each episode.
Who This Approach Serves
The infusion approach to chronic migraine is most relevant for patients who fall into one or more of the following clinical categories. Patients who have tried multiple oral preventive medications — beta-blockers, anticonvulsants, tricyclic antidepressants, CGRP inhibitors — without adequate reduction in migraine frequency. Patients whose acute migraine medications have become less effective over time or have produced medication overuse headache, a rebound phenomenon in which frequent analgesic use paradoxically increases headache frequency. Patients who have significant absorption or gastrointestinal issues that make oral medications unreliable. And patients whose migraines are accompanied by depression or anxiety, given ketamine’s documented effectiveness across both pain and mood disorder presentations (National Center for Biotechnology Information).
We also see patients who have had adequate diagnostic workup for their migraines but whose treatment plan has stalled — not because the diagnosis is unclear, but because the available oral options have been exhausted. If that description fits your situation, the infusion approach is worth a direct clinical conversation.
What Treatment Looks Like at Our Clinic
At Scottsdale Ketamine Clinic, every chronic migraine patient begins with a thorough intake evaluation. We review your migraine history, the treatments you have tried and how you responded, any co-occurring conditions, and your current medication regimen. Our clinical team, led by Jenice Hughes, CRNA, a board-certified nurse anesthetist with more than four decades of clinical experience in anesthesia and pain management, uses that information to determine whether IV ketamine is appropriate and to build a personalized treatment protocol.
Infusions are administered in private, comfortable treatment rooms at our Scottsdale and Phoenix locations. Each session lasts approximately 45 to 60 minutes with continuous vital sign monitoring throughout. The perceptual effects of ketamine — mild detachment, a temporary quieting of normal sensory experience — are temporary and resolve after the session ends. Patients must arrange transportation for infusion days; driving is not permitted.
We do not apply a uniform session count for chronic pain protocols. The number of infusions in an initial series and the maintenance schedule that follows are built around your clinical picture and your response as treatment progresses. Our team assesses your response at each stage and adjusts the plan accordingly.
The Cost and Insurance Picture
IV ketamine infusions for chronic migraine are off-label treatments and are not typically covered by insurance. We provide documentation for patients pursuing out-of-network reimbursement from their insurer, and our team covers the financial details fully before any treatment commitment is made. The IV vitamin therapy options at our clinic — including formulas designed to support migraine management such as the Classic Myers Cocktail — are available at lower price points for patients managing treatment costs across multiple approaches. Ask our team about all available options during your consultation.
Frequently Asked Questions
Can ketamine infusions stop a migraine that is already in progress? IV ketamine can be used acutely for migraine treatment, and many patients report meaningful relief during or shortly after a single infusion when presenting with an active migraine. However, the protocol we use at our clinic is primarily designed for the ongoing management of chronic migraine through a series of infusions rather than as a single acute rescue treatment. Discuss your acute versus preventive needs during the intake evaluation.
Will IV ketamine interact with my current migraine medications? This depends on your specific medications. Many patients on preventive migraine regimens have proceeded with ketamine infusions safely; others require review of potential interactions. All current medications are assessed during intake. Do not discontinue or modify existing migraine medications independently in anticipation of starting ketamine treatment.
How many sessions are typical for chronic migraine patients? We do not apply a fixed session count for chronic pain conditions. The protocol is individualized based on your history, your response to initial sessions, and your clinical goals. Our team assesses your response throughout and discusses next steps — including maintenance frequency — based on what the evidence from your sessions shows.
Is the infusion experience different for pain patients versus mental health patients? The infusion itself is structurally the same — same setting, same monitoring, same approximate duration. The dosing protocol may differ based on your condition and clinical picture. Our team calibrates the protocol for your specific presentation.
My migraines are also connected to significant anxiety and depression. Does that affect my candidacy? Not negatively. IV ketamine has documented effectiveness for both chronic pain and mood disorders, and the co-occurrence of migraine with depression and anxiety is actually a common presentation in our patient population. Discuss your full symptom picture during the intake evaluation — it helps us build a protocol that addresses the complete clinical picture rather than each condition in isolation.
Key Takeaways
- IV delivery bypasses the gastrointestinal absorption problems that make oral migraine medications unreliable during attacks, reaching therapeutic concentration in minutes rather than hours.
- Chronic migraine involves central sensitization — a system-level hypersensitization of the nervous system’s pain-processing network — that oral migraine medications were not designed to address at the NMDA receptor level.
- IV ketamine blocks overactive NMDA receptors and promotes neuroplasticity, addressing the pain amplification mechanism that sustains chronic migraine rather than suppressing individual episodes.
- The infusion approach is most relevant for patients who have exhausted oral preventive options, experienced medication overuse headache, or have co-occurring depression or anxiety alongside chronic migraine.
- IV ketamine for chronic migraine is off-label and not typically covered by insurance; full cost discussion and documentation for out-of-network reimbursement are available at Scottsdale Ketamine Clinic.
Chronic migraine does not have to be managed exclusively on its own recurring terms. If oral treatments have reached their ceiling and your migraines continue at the frequency and intensity that brought you to this page, the infusion approach represents a mechanism that has not yet been tested for your nervous system. Results vary by individual. Call our Scottsdale clinic at 480-613-3226 or our Phoenix location at 480-590-6154 to schedule a free consultation and find out whether it is a reasonable next step for your specific clinical picture. You can also review our ketamine FAQs to prepare for that conversation.
References
National Center for Biotechnology Information. Ketamine for Chronic Pain. https://www.ncbi.nlm.nih.gov/books/NBK539824/
National Center for Biotechnology Information. Migraines. https://pmc.ncbi.nlm.nih.gov/articles/PMC9506374/
National Center for Biotechnology Information. Depression and Pain. https://pmc.ncbi.nlm.nih.gov/articles/PMC5494581/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. IV ketamine infusion therapy for chronic migraine or chronic pain should only be pursued under the supervision of a licensed medical provider familiar with your complete medical history. Individual results vary. Not all patients are candidates for ketamine therapy. If you are experiencing a medical emergency, please call 911 or go to your nearest emergency room.
